Viruses detected among sporadic cases of parotitis, United States, 2009-2011.

BACKGROUND Sporadic cases of parotitis are generally assumed to be mumps, which often requires a resource-intensive public health response. This project surveyed the frequency of viruses detected among such cases. METHODS During 2009-2011, 8 jurisdictions throughout the United States investigated sporadic cases of parotitis. Epidemiologic information, serum, and buccal and oropharyngeal swabs were collected. Polymerase chain reaction methods were used to detect a panel of viruses. Anti-mumps virus immunoglobulin M (IgM) antibodies were detected using a variety of methods. RESULTS Of 101 specimens, 38 were positive for a single virus: Epstein-Barr virus (23), human herpesvirus (HHV)-6B (10), human parainfluenza virus (HPIV)-2 (3), HPIV-3 (1), and human bocavirus (1). Mumps virus, enteroviruses (including human parechovirus), HHV-6A, HPIV-1, and adenoviruses were not detected. Early specimen collection did not improve viral detection rate. Mumps IgM was detected in 17% of available specimens. Patients in whom a virus was detected were younger, but no difference was seen by sex or vaccination profile. No seasonal patterns were identified. CONCLUSIONS Considering the timing of specimen collection, serology results, patient vaccination status, and time of year may be helpful in assessing the likelihood that a sporadic case of parotitis without laboratory confirmation is mumps.

[1]  S. Stokley,et al.  National and State Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2012 , 2013, MMWR. Morbidity and mortality weekly report.

[2]  W. Bellini,et al.  Comparison of the Sensitivity of Laboratory Diagnostic Methods from a Well-Characterized Outbreak of Mumps in New York City in 2009 , 2013, Clinical and Vaccine Immunology.

[3]  O. Morgan,et al.  Hospitalization due to human parainfluenza virus–associated lower respiratory tract illness in rural Thailand , 2012, Influenza and other respiratory viruses.

[4]  H. D. de Melker,et al.  Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010. , 2012, Vaccine.

[5]  A. Lauhio,et al.  Herpes viruses lack association with acute parotitis in children. , 2011, The Pediatric infectious disease journal.

[6]  S. Deeks,et al.  An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada , 2011, Canadian Medical Association Journal.

[7]  M. Paunio,et al.  MMR vaccination and disease elimination: the Finnish experience , 2010, Expert review of vaccines.

[8]  John W. Glasser,et al.  Mumps resurgences in the United States: A historical perspective on unexpected elements. , 2009, Vaccine.

[9]  J. Mahony,et al.  Difficulty with mumps diagnosis: What is the contribution of mumps mimickers? , 2009, Journal of Clinical Virology.

[10]  D. Toney,et al.  Investigation of a mumps outbreak among university students with two measles–mumps–rubella (MMR) vaccinations, Virginia, September–December 2006 , 2009, Journal of medical virology.

[11]  G. Dowse,et al.  A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia , 2009, The Medical journal of Australia.

[12]  J. Hart,et al.  Mumps outbreak on the island of Anglesey, North Wales, December 2008-January 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  Cedric Brown,et al.  Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006. , 2008, Vaccine.

[14]  M. Pallansch,et al.  Detection of All Known Parechoviruses by Real-Time PCR , 2008, Journal of Clinical Microbiology.

[15]  Umesh Parashar,et al.  Recent resurgence of mumps in the United States. , 2008, The New England journal of medicine.

[16]  N. Yoshida,et al.  Mumps virus reinfection is not a rare event confirmed by reverse transcription loop‐mediated isothermal amplification , 2008, Journal of medical virology.

[17]  W. Carman,et al.  Comparison of mumps-IgM ELISAs in acute infection. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[18]  N. Andrews,et al.  Vaccine Effectiveness Estimates, 2004–2005 Mumps Outbreak, England , 2007, Emerging infectious diseases.

[19]  E. Shapiro,et al.  Human Bocavirus Infection in Young Children in the United States: Molecular Epidemiological Profile and Clinical Characteristics of a Newly Emerging Respiratory Virus , 2006, The Journal of infectious diseases.

[20]  Lori Hutwagner,et al.  Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Xiaoyan Lu,et al.  Real-Time PCR Assays for Detection of Bocavirus in Human Specimens , 2006, Journal of Clinical Microbiology.

[22]  M. Cormican,et al.  Importance of clinical features in diagnosis of mumps during a community outbreak. , 2006, Irish medical journal.

[23]  M. Pallansch,et al.  Enterovirus molecular detection and typing , 2005 .

[24]  Richard Harling,et al.  The effectiveness of the mumps component of the MMR vaccine: a case control study. , 2005, Vaccine.

[25]  A. Paananen,et al.  Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella. , 2005, The Journal of infectious diseases.

[26]  C. Baker,et al.  Red book®: 2003 report of the committee on infectious diseases. , 2016 .

[27]  A. Heim,et al.  Rapid and quantitative detection of human adenovirus DNA by real‐time PCR , 2003, Journal of medical virology.

[28]  M. Akın,et al.  Mumps-like syndrome owing to parvovirus B19: a brief report , 2002, Annals of tropical paediatrics.

[29]  P. Pellett,et al.  Quantitative, Fluorogenic Probe PCR Assay for Detection of Human Herpesvirus 8 DNA in Clinical Specimens , 2001, Journal of Clinical Microbiology.

[30]  S. Mcquone,et al.  Acute viral and bacterial infections of the salivary glands. , 1999, Otolaryngologic clinics of North America.

[31]  H. Kikuta,et al.  Analysis of Mumps Vaccine Failure by Means of Avidity Testing for Mumps Virus-Specific Immunoglobulin G , 1998, Clinical Diagnostic Laboratory Immunology.

[32]  R. Parker,et al.  Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. , 1994, The Journal of infectious diseases.

[33]  L. Grubhoffer,et al.  Contribution to laboratory diagnosis of mumps and parainfluenza. , 1988, Acta virologica.

[34]  Y. Ito,et al.  Enzyme-linked immunosorbent assay for mumps IgM antibody: comparison of IgM capture and indirect IgM assay. , 1985, Journal of virological methods.

[35]  H. Tuokko Comparison of nonspecific reactivity in indirect and reverse immunoassays for measles and mumps immunoglobulin M antibodies , 1984, Journal of clinical microbiology.

[36]  Iikka Julkunen Serological diagnosis of parainfluenza virus infections by enzyme immunoassay with special emphasis on purity of viral antigens , 1984, Journal of medical virology.

[37]  R. Tedder,et al.  Rubella-specific IgM reactivity in sera from cases of infectious mononucleosis , 1983, Journal of Hygiene.

[38]  T. Ziegler,et al.  Determination of IgG- and IgM-class antibodies to mumps virus by solid-phase enzyme immunoassay. , 1982, Journal of virological methods.

[39]  R. Gilfillan,et al.  Acute parotitis associated with influenza type A: a report of twelve cases. , 1977, The New England journal of medicine.

[40]  G. Klein,et al.  Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro , 1977, Nature.